Instalab

Research & Answers

Physician-backed insights to optimize your health and reduce long-term risks.

Killing Cutibacterium Acnes Might Be Making Your Acne Worse

The bacterium most associated with acne is also the one your skin needs most. Cutibacterium acnes (formerly known as Propionibacterium acnes) is the dominant microbe on sebum-rich skin, and research increasingly shows that acne is not caused by having too much of it. Instead, acne is tied to losing the diversity of C. acnes strains and the broader microbial community on your skin. That reframe changes everything about how acne should be treated. This is a bacterium with a genuine dual identity. On healthy skin, C. acnes supports homeostasis by modulating lipids, competing with harmful pathogens, and protecting against oxidative stress. But when the community structure shifts, specific strains dominate, and biofilms form, the same organism drives persistent, inflammatory skin disease.

Elevated Alkaline Phosphatase: Often Harmless, Sometimes the First Clue to Something Serious

When adults have an elevated alkaline phosphatase (ALP) with no obvious explanation, malignancy turns out to be the leading diagnosis roughly 57% of the time. That's a striking number for a lab value most people glance at and forget. ALP is an enzyme produced mainly by your liver and bones, and it shows up on routine blood panels. A high reading is common, frequently benign, and occasionally the earliest signal of significant disease, from metastatic cancer to cardiovascular risk you wouldn't otherwise suspect. The challenge is that ALP is nonspecific. It doesn't point to one thing. It points to a category of things, and figuring out which one matters is where context becomes everything.

Granulocytes Are Not Just Killers: Your Immune System's Most Underestimated Cells

The white blood cells you were taught simply rush in, destroy invaders, and die may actually be running far more of your immune system than anyone realized. Modern research has fundamentally shifted the view of granulocytes, moving them from "blunt instruments" to highly plastic, regulatory cells that present antigens, shape long-term immune responses, and even communicate with the sophisticated arm of your adaptive immunity. That upgrade in understanding matters because these cells sit at the center of infection, allergy, autoimmune disease, and tissue repair. The catch: the same machinery that makes granulocytes powerful defenders also makes them capable of serious collateral damage. Understanding how they work on both sides of that line is increasingly relevant to how diseases are tracked and treated.